• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) ONYX AVM; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) ONYX AVM; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number 105-7000-060
Device Problem Entrapment of Device (1212)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/04/2014
Event Type  Injury  
Manufacturer Narrative
The onyx was not returned for analysis; therefore the complaint could not be confirmed, and the event cause could not be determined.The lot history record review was not possible since the lot number was not reported.Mdr 2 of 2 this mdr is for the onyx 34 used in the procedure.Please reference mdr 2029214-2016-00791 for the onyx 18 used in this procedure.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that a competitor's catheter was found stuck, broken, and occluded with a relationship to the onyx during an embolization procedure of a dural arteriovenous fistula (davf).Under general anesthesia, the right femoral artery was punctured with short 6f introducer sheath.Catheterization of the left common artery using a vertebral catheter was completed, confirming persistence of the fistula without any significant change.The physician used a competitor's microcatheter with a 25 mm detachable tip on a hybrid microguide catheter, allowing distal catheterization of the squamous branch of the left middle meningeal artery.The physician injected 2.4 ml of onyx 18 followed by 1 ml of onyx 34 enabling the embolization of the suspended segment of the sigmoid sinus by filling the dural venous collectors as well as the extremities of the various arterial branches feeding this fistula.The final check showed an exclusion of the fistula.The microcatheter was stretched during removal, and it remained attached to the sheath.As a result, a microsnare-kit had to be used to recover it.There was no patient complication reported during this procedure.Per core lab review the microcatheter was stuck, broken, and occluded with onyx.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX AVM
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key5934540
MDR Text Key54141585
Report Number2029214-2016-00792
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number105-7000-060
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/07/2016
Initial Date FDA Received09/07/2016
Supplement Dates Manufacturer Received03/07/2016
Supplement Dates FDA Received09/25/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-